Opiant Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11, 2021
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will release its financial results for Q1 2021 on May 11, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will release its financial results for Q1 2021 on May 11, 2021, after market close. A conference call will follow at 4:30 PM ET the same day. Investors can join by dialing 877-407-0792 (U.S.) or 201-689-8263 (International) with the conference ID 13718590. The webcast will be available on the company's investor website.
Opiant is known for developing NARCAN® Nasal Spray and is focusing on creating new treatments for drug overdose and addiction.
Positive
- Scheduled Q1 2021 financial results announcement may provide investors insight into company performance.
- Company developing treatments for addictions and drug overdose, indicating potential growth in a critical healthcare sector.
Negative
- None.
Details
News Market Reaction – OPNT
The recorded move for OPNT in the trading session of this news was +0.57%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA MONICA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the first quarter ended March 31, 2021, after the financial markets close on Tuesday, May 11, 2021.
The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Tuesday May 11, 2021. To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13718590. To access the live webcast, please go to the investors section of Opiant’s website at http://ir.opiant.com/. Following the live webcast, an archived version of the call will be available on the website.
| Tuesday May 11 @ 4:30 pm ET | |
| Domestic: | 877-407-0792 |
| International: | 201-689-8263 |
| Conference ID: | 13718590 |
| Webcast: | http://ir.opiant.com/ |
About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
For more information visit: www.opiant.com.
For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.